CN103555641B - A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof - Google Patents
A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof Download PDFInfo
- Publication number
- CN103555641B CN103555641B CN201310579845.6A CN201310579845A CN103555641B CN 103555641 B CN103555641 B CN 103555641B CN 201310579845 A CN201310579845 A CN 201310579845A CN 103555641 B CN103555641 B CN 103555641B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- mycoplasma hyopneumoniae
- parts
- culture medium
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title claims abstract description 50
- 239000001963 growth medium Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 53
- 150000004676 glycans Chemical class 0.000 claims abstract description 46
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 46
- 239000005017 polysaccharide Substances 0.000 claims abstract description 46
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 150000001413 amino acids Chemical class 0.000 claims abstract description 16
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 11
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 210000002966 serum Anatomy 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000006228 supernatant Substances 0.000 claims description 16
- 235000001014 amino acid Nutrition 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 239000008055 phosphate buffer solution Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 8
- 240000000031 Achyranthes bidentata Species 0.000 claims description 7
- 241000007126 Codonopsis pilosula Species 0.000 claims description 7
- 244000194101 Ginkgo biloba Species 0.000 claims description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims description 7
- 244000197580 Poria cocos Species 0.000 claims description 7
- 235000008599 Poria cocos Nutrition 0.000 claims description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 7
- 229940010454 licorice Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 5
- 229930064664 L-arginine Natural products 0.000 claims description 5
- 235000014852 L-arginine Nutrition 0.000 claims description 5
- 239000004201 L-cysteine Substances 0.000 claims description 5
- 235000013878 L-cysteine Nutrition 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 241000204003 Mycoplasmatales Species 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 8
- 239000002609 medium Substances 0.000 abstract description 6
- 239000008363 phosphate buffer Substances 0.000 abstract description 6
- 238000012258 culturing Methods 0.000 abstract description 4
- 230000006907 apoptotic process Effects 0.000 abstract description 2
- 238000011109 contamination Methods 0.000 abstract description 2
- 241000282898 Sus scrofa Species 0.000 description 16
- 238000000034 method Methods 0.000 description 7
- 241000202807 Glycyrrhiza Species 0.000 description 6
- 241000204031 Mycoplasma Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 101001032860 Mus musculus Gremlin-2 Proteins 0.000 description 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000202347 Porcine circovirus Species 0.000 description 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000725681 Swine influenza virus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种猪肺炎支原体培养基及其制备方法,属于兽用生物制品技术领域。其每1000ml磷酸缓冲液中含有PPLO 20~50g、酵母粉2~10g、葡萄糖3~15g、1%酚红0.5~4ml、氨基酸组合2~10g、复方中药多糖15~30g和猪血清50~100ml。本发明的猪肺炎支原体培养基,在培养猪肺炎支原体时可以提高猪肺炎支原体耐受力,降低猪肺炎支原体凋亡率;本发明的猪肺炎支原体培养基,可以提高猪肺炎支原体培养菌数,培养菌液浓度达1010-11/ml,比普通培养基提高5-10倍以上;本发明的猪肺炎支原体培养基,在培养猪肺炎支原体时可以同时抑制其他细菌生长,降低培养猪肺炎支原体培养的污染风险。A culture medium for mycoplasma hyopneumoniae and a preparation method thereof belong to the technical field of veterinary biological products. Each 1000ml of phosphate buffer contains 20-50g of PPLO, 2-10g of yeast powder, 3-15g of glucose, 0.5-4ml of 1% phenol red, 2-10g of amino acid combination, 15-30g of compound Chinese medicine polysaccharide and 50-100ml of pig serum . The mycoplasma hyopneumoniae culture medium of the present invention can improve the tolerance of mycoplasma hyopneumoniae and reduce the apoptosis rate of mycoplasma hyopneumoniae when culturing mycoplasma hyopneumoniae; The concentration of the cultured bacteria reaches 10 10-11 /ml, which is more than 5-10 times higher than that of ordinary medium; the Mycoplasma hyopneumoniae culture medium of the present invention can inhibit the growth of other bacteria at the same time when cultivating Mycoplasma hyopneumoniae, and reduce the growth rate of Mycoplasma hyopneumoniae. Cultured contamination risk.
Description
技术领域 technical field
本发明属于兽用生物制品技术领域,具体涉及一种猪肺炎支原体培养基及其制备方法。 The invention belongs to the technical field of veterinary biological products, and in particular relates to a culture medium for mycoplasma hyopneumoniae and a preparation method thereof.
背景技术 Background technique
猪支原体肺炎是猪场一种极为常见的呼吸道疾病,在全世界范围内流行,俗称猪气喘病,由猪肺炎支原体(Mhp)所导致,该病原在猪体内主要寄居在气管、支气管和细支气管的纤毛上,严重破坏猪呼吸道的物理防卫机制-防御粘膜,增加了猪群对其它呼吸性病原体的易感性,如猪流感病毒,猪繁殖和呼吸道综合征病毒,Ⅱ型猪圆环病毒,支气管败血波氏杆菌,胸膜肺炎放线杆菌和副猪嗜血杆菌等,所以常常造成多种病原的复合感染,引发猪呼吸道综合征(PRDC)或者其他疾病,肺炎支原体可降低猪生长率12.7%和降低饲料报酬13.8%,严重危害养猪业的发展。 Mycoplasma swine pneumonia is a very common respiratory disease in pig farms. It is prevalent all over the world. It is commonly known as swine asthma. It is caused by Mycoplasma hyopneumoniae (Mhp). The pathogen mainly resides in the trachea, bronchi and bronchioles in pigs On the cilia of the pig's respiratory tract, it severely damages the physical defense mechanism of the pig's respiratory tract - the defense mucosa, which increases the susceptibility of the pig herd to other respiratory pathogens, such as swine influenza virus, porcine reproductive and respiratory syndrome virus, type Ⅱ porcine circovirus, bronchial Bordetella septica, Actinobacillus pleuropneumoniae and Haemophilus parasuis, etc., often cause complex infections of multiple pathogens, causing porcine respiratory syndrome (PRDC) or other diseases, Mycoplasma pneumoniae can reduce pig growth rate by 12.7% And reduce the feed remuneration by 13.8%, seriously endangering the development of the pig industry.
猪肺炎支原体为兼性厌氧菌,生长需求极为苛刻,分离相当困难,它对营养要求比一般的支原体高。猪肺炎支原体虽然能够利用培养基中的营养合成自身生长繁殖所需的物质,但由于其基因组的分子量较小,携带的信息量不多,生物合成能力有限,因此需要从体外摄取胆固醇、氨基酸、脂肪酸、核酸前体及维生素等物质,这就促使支原体的培养基成分比较复杂,必须添加一些特殊营养物质。 Mycoplasma hyopneumoniae is a facultative anaerobic bacterium with extremely demanding growth requirements and difficult isolation. It has higher nutritional requirements than ordinary mycoplasma. Although Mycoplasma hyopneumoniae can use the nutrients in the culture medium to synthesize the substances needed for its own growth and reproduction, due to the small molecular weight of its genome, the amount of information it carries is not much, and its biosynthetic ability is limited. Therefore, it needs to ingest cholesterol, amino acids, Fatty acids, nucleic acid precursors and vitamins and other substances, which make the composition of the culture medium of mycoplasma more complicated, and some special nutrients must be added.
由于猪肺炎支原体对营养要求比一般支原体高,培养基成分比较复杂,培养时间长,培养物浓度较低,大大地影响了人们对其进一步地研究,同时也阻碍了猪肺炎支原体疫苗开发与生产。目前不少学者设计了多种培养基来供其生长,尽管它们各具特色,但总的说来都没有解决培养困难的问题。所以在猪肺炎支原体的培养上还要做进一步研究。 Because Mycoplasma hyopneumoniae has higher nutritional requirements than ordinary Mycoplasma, the composition of the medium is more complex, the culture time is long, and the culture concentration is low, which greatly affects people's further research on it, and also hinders the development and production of Mycoplasma hyopneumoniae vaccine. . At present, many scholars have designed a variety of culture media for its growth. Although they have their own characteristics, they have not solved the problem of difficult cultivation in general. Therefore, further research should be done on the cultivation of Mycoplasma hyopneumoniae.
多糖是中药活性成分之一,大量研究表明,多糖及糖复合物在生物体内不仅是作为能量资源和构成材料,更重要的是它存在于一切细胞膜结构中,参与生命现象中细胞的各种活动。多糖类物质是所有生命有机体的重要组成部分,具有清除自由基、提高抗氧化酶活性和抑制脂质过氧化的能力。此外,中药多糖对低等生物具有特殊的保护作用。中药多糖富含羟基,可以和低等活性生物活体结合,构建多维网络空间氢键结构,在活性生物活体表面形成保护膜,实现对活性生物的保护作用。 Polysaccharides are one of the active ingredients of traditional Chinese medicine. A large number of studies have shown that polysaccharides and sugar complexes are not only used as energy resources and constituent materials in organisms, but more importantly, they exist in all cell membrane structures and participate in various activities of cells in life phenomena. . Polysaccharides are an important part of all living organisms and have the ability to scavenge free radicals, increase the activity of antioxidant enzymes and inhibit lipid peroxidation. In addition, traditional Chinese medicine polysaccharides have special protective effects on lower organisms. Chinese medicine polysaccharides are rich in hydroxyl groups, which can combine with low-level living organisms to build a multi-dimensional network space hydrogen bond structure, form a protective film on the surface of living organisms, and realize the protection of living organisms.
本发明基于上述技术背景,提出一种支原体培养基,具体是一种特别适用于猪肺炎支原体的培养基,提高了猪肺炎支原体菌液浓度。 Based on the above technical background, the present invention proposes a mycoplasma culture medium, specifically a culture medium especially suitable for mycoplasma hyopneumoniae, which increases the concentration of mycoplasma hyopneumoniae bacterial liquid.
发明内容 Contents of the invention
针对现有技术存在的问题,本发明的目的在于设计提供一种猪肺炎支原体培养基及其制备方法的技术方案,通过该培养基培养猪肺炎支原体,可提高猪肺炎支原体菌液浓度,提高猪肺炎支原体抗原产量。 In view of the problems existing in the prior art, the purpose of the present invention is to design and provide a technical scheme for a Mycoplasma hyopneumoniae culture medium and a preparation method thereof. By cultivating Mycoplasma hyopneumoniae through the culture medium, the concentration of Mycoplasma hyopneumoniae bacterium can be increased, and the growth rate of Mycoplasma hyopneumoniae can be improved. Mycoplasma antigen production.
所述的一种猪肺炎支原体培养基,其特征在于每1000ml磷酸缓冲液中含有以下重量配比的组分: Described a kind of Mycoplasma hyopneumoniae culture medium is characterized in that every 1000ml phosphate buffer contains the following weight ratio components:
PPLO 20~50g PPLO 20~50g
酵母粉 2~10g Yeast powder 2~10g
葡萄糖 3~15g Glucose 3~15g
1%酚红 0.5~4ml 1% phenol red 0.5~4ml
氨基酸组合 2~10g Amino acid combination 2~10g
复方中药多糖 15~30g Compound traditional Chinese medicine polysaccharide 15~30g
猪血清 50~100ml; Pig serum 50~100ml;
所述的氨基酸组合中含有L-精氨酸、甘氨酸、酪氨酸、L-半胱氨酸和丝氨酸; The amino acid combination contains L-arginine, glycine, tyrosine, L-cysteine and serine;
所述的复方中药多糖从以下中药组合物中提取得到:黄连、银杏叶、怀牛膝、党参、茯苓、枸杞、甘草和丹参。 The compound traditional Chinese medicine polysaccharide is extracted from the following traditional Chinese medicine compositions: Coptis chinensis, Ginkgo biloba, Achyranthes bidentata, Codonopsis pilosula, Poria cocos, wolfberry, licorice and salvia miltiorrhiza.
所述的一种猪肺炎支原体培养基,其特征在于每1000ml磷酸缓冲液中含有以下重量配比的组分: Described a kind of Mycoplasma hyopneumoniae culture medium is characterized in that every 1000ml phosphate buffer contains the following weight ratio components:
PPLO 30~40g PPLO 30~40g
酵母粉 4~8g Yeast powder 4~8g
葡萄糖 5~10g Glucose 5~10g
1%酚红 1~3ml 1% phenol red 1~3ml
氨基酸组合 4~8g Amino acid combination 4~8g
复方中药多糖 20~25g Compound traditional Chinese medicine polysaccharide 20~25g
猪血清 60~80ml。 Pig serum 60-80ml.
所述的一种猪肺炎支原体培养基,其特征在于所述的氨基酸组合含有L-精氨酸10~30%、甘氨酸5~15%、酪氨酸10~30%、L-半胱氨酸20~40%和丝氨酸10~30%。 The Mycoplasma hyopneumoniae culture medium is characterized in that the amino acid combination contains 10-30% of L-arginine, 5-15% of glycine, 10-30% of tyrosine, and 20% of L-cysteine. ~40% and serine 10~30%.
所述的一种猪肺炎支原体培养基,其特征在于所述的复方中药多糖从以下中药组合物中提取得到:黄连5~15份、银杏叶10~30份、怀牛膝10~20份、党参10~30份、茯苓5~50份、枸杞10~30份、甘草10~20份和丹参5~15份。 The Mycoplasma hyopneumoniae culture medium is characterized in that the compound Chinese medicine polysaccharide is extracted from the following Chinese medicine compositions: 5-15 parts of Coptidis Rhizome, 10-30 parts of Ginkgo biloba, 10-20 parts of Achyranthes bidentata, Codonopsis pilosula 10-30 parts, Poria cocos 5-50 parts, wolfberry 10-30 parts, licorice 10-20 parts and salvia miltiorrhiza 5-15 parts.
所述的一种猪肺炎支原体培养基,其特征在于所述的复方中药多糖通过以下步骤制得: Described a kind of Mycoplasma hyopneumoniae culture medium is characterized in that described compound Chinese medicine polysaccharide is made through the following steps:
a、称取各中药原料,切碎、洗净后用冷水浸泡过夜,再加入原料重量15倍的纯化水,水浴至90℃,并保持在90℃,熬制2小时,熬制过程中每10分钟搅拌一次; a. Weigh each raw material of traditional Chinese medicine, chop it up, wash it, soak it in cold water overnight, then add purified water 15 times the weight of the raw material, take a water bath to 90°C, and keep it at 90°C, and boil for 2 hours. Stir once every 10 minutes;
b、弃去a中药渣,收集药液,室温冷却后经10000rpm离心10分钟,弃去沉淀,收集上清; b. Discard the dregs of the traditional Chinese medicine in a, collect the medicinal liquid, and centrifuge at 10,000 rpm for 10 minutes after cooling at room temperature, discard the precipitate, and collect the supernatant;
c、将b中上清进行醇沉,沉淀即为粗制中药多糖; c. The supernatant in b is subjected to alcohol precipitation, and the precipitation is crude Chinese medicine polysaccharide;
d、用灭菌纯化水洗涤c中粗制中药多糖,洗涤后用20倍量的42℃灭菌纯化水进行溶解,溶解后,按0.5%比例加入活性炭4℃吸附过夜,吸附后经10000rpm离心10分钟,弃去沉淀,收集上清; d. Wash the crude traditional Chinese medicine polysaccharide in c with sterilized purified water. After washing, dissolve it with 20 times the amount of sterilized purified water at 42°C. After dissolving, add activated carbon at a ratio of 0.5% to absorb overnight at 4°C. After adsorption, centrifuge at 10,000 rpm After 10 minutes, discard the precipitate and collect the supernatant;
e、将d中上清经0.22um滤膜过滤除菌后,进行10倍浓缩,制得中药多糖浓缩液; e. After the supernatant in d is filtered and sterilized by a 0.22um filter membrane, it is concentrated 10 times to obtain a Chinese medicine polysaccharide concentrate;
f、将e中中药多糖浓缩液进行真空冷冻干燥即得到复方中药多糖。 f. Vacuum freeze-drying the concentrated Chinese medicine polysaccharide in e to obtain the compound Chinese medicine polysaccharide.
所述的一种猪肺炎支原体培养基的制备方法,其特征在于包括以下工艺步骤: The preparation method of described a kind of Mycoplasma hyopneumoniae culture medium is characterized in that comprising the following processing steps:
1)配制磷酸缓冲溶液; 1) Prepare phosphate buffer solution;
2)从黄连5~15份、银杏叶10~30份、怀牛膝10~20份、党参10~30份、茯苓5~50份、枸杞10~30份、甘草10~20份和丹参5~15份中提取得到复方中药多糖; 2) 5-15 parts of Coptis chinensis, 10-30 parts of Ginkgo biloba, 10-20 parts of Achyranthes bidentata, 10-30 parts of Codonopsis pilosula, 5-50 parts of Poria cocos, 10-30 parts of wolfberry, 10-20 parts of licorice and 5 parts of salvia miltiorrhiza ~15 parts were extracted to obtain compound Chinese medicine polysaccharides;
3)称取PPLO 20~50g、酵母粉2~10g、葡萄糖3~15g、氨基酸组合2~10g、复方中药多糖15~30g,溶解于步骤1)制得的1000mL磷酸缓冲溶液中,加入1%酚红0.5~4ml充分混匀,用酸或碱调节pH至7.4~7.8之间,无菌条件下通过0.22μm滤膜,过滤除菌后置4℃保存备用,使用前添加健康猪血清50~100ml,得到猪肺炎支原体培养基。 3) Weigh 20-50g of PPLO, 2-10g of yeast powder, 3-15g of glucose, 2-10g of amino acid combination, 15-30g of compound Chinese medicine polysaccharide, dissolve in the 1000mL phosphate buffer solution prepared in step 1), add 1% Mix 0.5-4ml of phenol red thoroughly, adjust the pH to 7.4-7.8 with acid or alkali, pass through a 0.22μm filter membrane under aseptic conditions, filter and sterilize, store at 4°C for later use, add healthy pig serum 50-70℃ before use 100ml to obtain the Mycoplasma hyopneumoniae culture medium.
所述的一种猪肺炎支原体培养基的制备方法,其特征在于所述的步骤2)中复方中药多糖通过以下步骤制得: The method for preparing a culture medium for Mycoplasma hyopneumoniae is characterized in that the compound Chinese medicine polysaccharide in the step 2) is prepared through the following steps:
a、称取各中药原料,切碎、洗净后用冷水浸泡过夜,再加入原料重量15倍的纯化水,水浴至90℃,并保持在90℃,熬制2小时,熬制过程中每10分钟搅拌一次; a. Weigh each raw material of traditional Chinese medicine, chop it up, wash it, soak it in cold water overnight, then add purified water 15 times the weight of the raw material, take a water bath to 90°C, and keep it at 90°C, and boil for 2 hours. Stir once every 10 minutes;
b、弃去a中药渣,收集药液,室温冷却后经10000rpm离心10分钟,弃去沉淀,收集上清; b. Discard the dregs of the traditional Chinese medicine in a, collect the medicinal liquid, and centrifuge at 10,000 rpm for 10 minutes after cooling at room temperature, discard the precipitate, and collect the supernatant;
c、将b中上清进行醇沉,沉淀即为粗制中药多糖; c. The supernatant in b is subjected to alcohol precipitation, and the precipitation is crude Chinese medicine polysaccharide;
d、用灭菌纯化水洗涤c中粗制中药多糖,洗涤后用20倍量的42℃灭菌纯化水进行溶解,溶解后,按0.5%比例加入活性炭4℃吸附过夜,吸附后经10000rpm离心10分钟,弃去沉淀,收集上清; d. Wash the crude traditional Chinese medicine polysaccharide in c with sterilized purified water. After washing, dissolve it with 20 times the amount of sterilized purified water at 42°C. After dissolving, add activated carbon at a ratio of 0.5% to absorb overnight at 4°C. After adsorption, centrifuge at 10,000 rpm After 10 minutes, discard the precipitate and collect the supernatant;
e、将d中上清经0.22um滤膜过滤除菌后,进行10倍浓缩,制得中药多糖浓缩液; e. After the supernatant in d is filtered and sterilized by a 0.22um filter membrane, it is concentrated 10 times to obtain a Chinese medicine polysaccharide concentrate;
f、将e中中药多糖浓缩液进行真空冷冻干燥即得到复方中药多糖。 f. Vacuum freeze-drying the concentrated Chinese medicine polysaccharide in e to obtain the compound Chinese medicine polysaccharide.
所述的一种猪肺炎支原体培养基的制备方法,其特征在于所述的步骤3)中所述的氨基酸组合含有L-精氨酸10~30%、甘氨酸5~15%、酪氨酸10~30%、L-半胱氨酸20~40%和丝氨酸10~30%。 The method for preparing a culture medium for Mycoplasma hyopneumoniae is characterized in that the amino acid combination described in step 3) contains 10-30% of L-arginine, 5-15% of glycine, and 10-15% of tyrosine. 30%, L-cysteine 20-40% and serine 10-30%.
所述的一种猪肺炎支原体培养基的制备方法,其特征在于所述的步骤3)中称取PPLO 30~40g、酵母粉7~8g、葡萄糖5~10g、氨基酸组合4~8g、复方中药多糖20~25g,溶解于步骤1)制得的1000mL磷酸缓冲溶液中,加入1%酚红1~3ml充分混匀,用酸或碱调节pH至7.4~7.8之间,无菌条件下通过0.22μm滤膜,过滤除菌后置4℃保存备用,使用前添加健康猪血清60~80ml。 The preparation method of a Mycoplasma hyopneumoniae culture medium is characterized in that in the step 3), PPLO 30-40g, yeast powder 7-8g, glucose 5-10g, amino acid combination 4-8g, compound Chinese medicine polysaccharide 20 ~ 25g, dissolved in 1000mL phosphate buffer solution prepared in step 1), add 1% phenol red 1 ~ 3ml and mix well, adjust the pH to 7.4 ~ 7.8 with acid or alkali, pass through 0.22μm under sterile conditions filter membrane, filter and sterilize, store at 4°C for later use, add 60-80ml of healthy pig serum before use.
本发明中PPLO 为PPLO培养基由森贝伽(南京)生物科技有限公司购得。 In the present invention, PPLO refers to the purchase of PPLO medium by Senbeijia (Nanjing) Biotechnology Co., Ltd.
与现有技术相比,本发明具有以下有益效果: Compared with the prior art, the present invention has the following beneficial effects:
(1)本发明所制备的猪肺炎支原体培养基,在培养猪肺炎支原体时可以提高猪肺炎支原体耐受力,降低猪肺炎支原体凋亡率。 (1) The Mycoplasma hyopneumoniae culture medium prepared by the present invention can improve the tolerance of Mycoplasma hyopneumoniae and reduce the apoptosis rate of Mycoplasma hyopneumoniae when culturing Mycoplasma hyopneumoniae.
(2)本发明所制备的猪肺炎支原体培养基,可以提高猪肺炎支原体培养菌数,培养菌液浓度达1010-11/ml(ccu计数法),比普通培养基提高5-10倍以上。 (2) The mycoplasma hyopneumoniae culture medium prepared by the present invention can increase the number of cultured bacteria of mycoplasma hyopneumoniae, and the concentration of the cultured bacteria liquid reaches 10 10-11 /ml (ccu counting method), which is more than 5-10 times higher than that of ordinary culture medium .
(3)本发明所制备的猪肺炎支原体培养基,在培养猪肺炎支原体时可以同时抑制其他细菌生长,降低培养猪肺炎支原体培养的污染风险。 (3) The culture medium for Mycoplasma hyopneumoniae prepared by the present invention can inhibit the growth of other bacteria at the same time when culturing Mycoplasma hyopneumoniae, and reduce the contamination risk of culturing Mycoplasma hyopneumoniae.
具体实施方式 Detailed ways
为了使本发明更加容易理解,下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。 In order to make the present invention easier to understand, the present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention.
实施例1 Example 1
一种猪肺炎支原体培养基,该培养基每1000ml磷酸缓冲液中含有以下重量配比的组分: A kind of mycoplasma hyopneumoniae culture medium, this culture medium contains the following components in weight ratio in every 1000ml phosphate buffer:
PPLO 20g PPLO 20g
酵母粉 6g Yeast powder 6g
葡萄糖 8g Glucose 8g
1%酚红 4ml 1% phenol red 4ml
氨基酸组合 4g Amino acid combination 4g
复方中药多糖 15g Compound Traditional Chinese Medicine Polysaccharide 15g
猪血清 50ml Pig Serum 50ml
一种猪肺炎支原体培养基的制备方法,其步骤是: A preparation method for mycoplasma hyopneumoniae culture medium, the steps are:
(1)磷酸缓冲溶液的配制:准确称取氯化钠8g,氯化钾0.2g,磷酸氢二钠1.15g,磷酸二氢钾0.2g,氯化钙0.1g,含6个结晶水的氯化镁0.1g溶于1000ml双蒸水中,无菌条件下通过0.22μm滤膜,过滤除菌备用。 (1) Preparation of phosphate buffer solution: Accurately weigh 8g of sodium chloride, 0.2g of potassium chloride, 1.15g of disodium hydrogen phosphate, 0.2g of potassium dihydrogen phosphate, 0.1g of calcium chloride, and magnesium chloride containing 6 crystal water Dissolve 0.1g in 1000ml double distilled water, pass through a 0.22μm filter membrane under aseptic conditions, filter and sterilize for later use.
(2)复方中药多糖的制备 (2) Preparation of compound traditional Chinese medicine polysaccharides
按黄连15份、银杏叶30份、怀牛膝10份、党参10份、茯苓20份、枸杞10份、甘草10份和丹参15份称取各中药原料,切碎、洗净后用冷水浸泡过夜,再加入原料重量15倍的纯化水,水浴至90℃,并保持在90℃,熬制2小时,熬制过程中每10分钟搅拌一次; 15 parts of Coptis chinensis, 30 parts of Ginkgo biloba, 10 parts of Achyranthes bidentata, 10 parts of Codonopsis pilosula, 20 parts of Poria cocos, 10 parts of wolfberry, 10 parts of licorice and 15 parts of salvia miltiorrhiza were weighed, chopped, washed and soaked in cold water Overnight, then add purified water 15 times the weight of the raw material, take a water bath to 90°C, and keep it at 90°C, cook for 2 hours, and stir every 10 minutes during the cooking process;
b、弃去a中药渣,收集药液,室温冷却后经10000rpm离心10分钟,弃去沉淀,收集上清; b. Discard the dregs of the traditional Chinese medicine in a, collect the medicinal liquid, and centrifuge at 10,000 rpm for 10 minutes after cooling at room temperature, discard the precipitate, and collect the supernatant;
c、将b中上清进行醇沉,沉淀即为粗制中药多糖; c. The supernatant in b is subjected to alcohol precipitation, and the precipitation is crude Chinese medicine polysaccharide;
d、用灭菌纯化水洗涤c中粗制中药多糖,洗涤后用20倍量的42℃灭菌纯化水进行溶解,溶解后,按0.5%比例加入活性炭4℃吸附过夜,吸附后经10000rpm离心10分钟,弃去沉淀,收集上清; d. Wash the crude traditional Chinese medicine polysaccharide in c with sterilized purified water. After washing, dissolve it with 20 times the amount of sterilized purified water at 42°C. After dissolving, add activated carbon at a ratio of 0.5% to absorb overnight at 4°C. After adsorption, centrifuge at 10,000 rpm After 10 minutes, discard the precipitate and collect the supernatant;
e、将d中上清经0.22um滤膜过滤除菌后,进行10倍浓缩,制得中药多糖浓缩液; e. After the supernatant in d is filtered and sterilized by a 0.22um filter membrane, it is concentrated 10 times to obtain a Chinese medicine polysaccharide concentrate;
f、将e中中药多糖浓缩液进行真空冷冻干燥即得到复方中药多糖。 f. Vacuum freeze-drying the concentrated Chinese medicine polysaccharide in e to obtain the compound Chinese medicine polysaccharide.
(3)猪肺炎支原体培养基的配制:按比例称取PPLO 20g、酵母粉6g、葡萄糖8g、1%酚红4ml、氨基酸组合4g(L-精氨酸0.8g、甘氨酸0.4g、酪氨酸1.0g、L-半胱氨酸1.2g和丝氨酸0.6g)、复方中药多糖15g,溶解于步骤(1)制得的磷酸缓冲溶液中,加入1%酚红4mL充分混匀,用酸或碱调节pH至7.4~7.8之间,无菌条件下通过0.22μm滤膜,过滤除菌后置4℃保存备用,使用前添加健康猪血清50ml。 (3) Preparation of Mycoplasma hyopneumoniae medium: Weigh 20g of PPLO, 6g of yeast powder, 8g of glucose, 4ml of 1% phenol red, 4g of amino acid combination (0.8g of L-arginine, 0.4g of glycine, tyrosine 1.0g, L-cysteine 1.2g and serine 0.6g), compound Chinese medicine polysaccharide 15g, dissolve in the phosphate buffer solution prepared in step (1), add 1% phenol red 4mL and mix well, add acid or alkali Adjust the pH to 7.4-7.8, pass through a 0.22 μm filter membrane under aseptic conditions, filter and sterilize, store at 4°C for later use, and add 50 ml of healthy pig serum before use.
实施例2 Example 2
一种猪肺炎支原体培养基,该培养基每1000ml磷酸缓冲液中含有以下重量配比的组分: A kind of mycoplasma hyopneumoniae culture medium, this culture medium contains the following components in weight ratio in every 1000ml phosphate buffer:
PPLO 35g PPLO 35g
酵母粉 2g Yeast powder 2g
葡萄糖 15g Glucose 15g
1%酚红 0.5ml 1% phenol red 0.5ml
氨基酸组合 10g Amino acid combination 10g
复方中药多糖 30g Compound Traditional Chinese Medicine Polysaccharide 30g
猪血清 80ml。 Pig serum 80ml.
一种猪肺炎支原体培养基的制备方法,其步骤同实施例1。其中复方中药多糖从黄连10份、银杏叶20份、怀牛膝15份、党参20份、茯苓50份、枸杞20份、甘草15份和丹参5份中提取得到。 A preparation method of a mycoplasma hyopneumoniae culture medium, the steps of which are the same as in Example 1. The compound traditional Chinese medicine polysaccharide is extracted from 10 parts of Coptis chinensis, 20 parts of Ginkgo biloba, 15 parts of Achyranthes bidentata, 20 parts of Codonopsis pilosula, 50 parts of Poria cocos, 20 parts of wolfberry, 15 parts of licorice and 5 parts of salvia miltiorrhiza.
实施例3 Example 3
一种猪肺炎支原体培养基,该培养基每1000ml磷酸缓冲液中含有以下重量配比的组分: A kind of mycoplasma hyopneumoniae culture medium, this culture medium contains the following components in weight ratio in every 1000ml phosphate buffer:
PPLO 50g PPLO 50g
酵母粉 10g Yeast powder 10g
葡萄糖 3g Glucose 3g
1%酚红 2.5ml 1% phenol red 2.5ml
氨基酸组合 2g Amino acid combination 2g
复方中药多糖 25g Compound Traditional Chinese Medicine Polysaccharide 25g
猪血清 100ml。 Pig serum 100ml.
一种猪肺炎支原体培养基的制备方法,其步骤同实施例1。其中复方中药多糖从黄连5份、银杏叶10份、怀牛膝20份、党参30份、茯苓5份、枸杞30份、甘草20份和丹参10份中提取得到。 A preparation method of a mycoplasma hyopneumoniae culture medium, the steps of which are the same as in Example 1. The compound traditional Chinese medicine polysaccharide is extracted from 5 parts of Coptis chinensis, 10 parts of Ginkgo biloba, 20 parts of Achyranthes bidentata, 30 parts of Codonopsis pilosula, 5 parts of Poria cocos, 30 parts of wolfberry, 20 parts of licorice and 10 parts of salvia miltiorrhiza.
比较例1 本发明所制备的培养基与常用培养基比较试验 Comparative example 1 culture medium prepared by the present invention and conventional culture medium comparison test
1 Mhp菌株和培养条件 1 Mhp strains and culture conditions
将购自ATCC的猪肺炎支原体J株分别接种实施例1的猪肺炎支原体培养基和现有技术的2种猪肺炎支原体培养基,按5%(V/V)的比例接种猪肺炎支原体于各培养基中,37℃培养,当培养基颜色变黄,pH降至6.4-6.8时,无菌取出培养物。 The Mycoplasma hyopneumoniae J strain purchased from ATCC was respectively inoculated with the Mycoplasma hyopneumoniae culture medium of Example 1 and the two kinds of Mycoplasma hyopneumoniae culture medium of the prior art, and was inoculated with Mycoplasma hyopneumoniae in each culture medium at a ratio of 5% (V/V). culture medium at 37°C, when the color of the medium turns yellow and the pH drops to 6.4-6.8, take out the culture aseptically.
2 活菌计数(CCU法) 2 Viable count (CCU method)
每个菌株培养物取14只无菌试管,每管装4.5ml含猪肺炎支原体培养基,在第1管加入0.5ml生长良好的培养物,混合均匀后,吸取0.5ml加入第2只管,如此进行10倍系列稀释至最后一管,同时设未加菌液的猪肺炎支原体培养基作为阴性对照。试验管作三个重复。系列稀释后将试管放置37℃恒温培养箱中静止培养,每日观察一次,主要观察培养基的颜色变化和浑浊度,连续观察时间为14日,最后发生颜色变化的小管稀释度即为该培养物的CCU滴度。 Take 14 sterile test tubes for each strain culture, each tube is filled with 4.5ml of culture medium containing Mycoplasma hyopneumoniae, add 0.5ml of well-grown culture to the first tube, after mixing evenly, draw 0.5ml into the second tube, and so on Perform a 10-fold serial dilution to the last tube, and set the Mycoplasma hyopneumoniae culture medium without bacterial solution as a negative control. Test tubes were run in triplicate. After serial dilution, place the test tube in a constant temperature incubator at 37°C for static culture, observe once a day, mainly observe the color change and turbidity of the medium, the continuous observation time is 14 days, the dilution of the small tube with the last color change is the culture The CCU titer of the substance.
3 结果 3 results
3.1 猪肺炎支原体Z株接种3种培养基3次生长实验CCU测定结果见表1。 3.1 See Table 1 for the CCU measurement results of three growth experiments in which the Z strain of Mycoplasma hyopneumoniae was inoculated with three kinds of media.
表1 猪肺炎支原体Z株接种3种培养基3次生长实验CCU测定结果 Table 1 The CCU measurement results of three growth experiments of Mycoplasma hyopneumoniae Z strain inoculated with three kinds of media
本发明所制备的猪肺炎支原体培养基,可以提高猪肺炎支原体培养菌数,培养菌液浓度达1010-11/ml(ccu计数法),比普通培养基提高5-10倍以上。 The mycoplasma hyopneumoniae culture medium prepared by the invention can increase the number of mycoplasma hyopneumoniae cultured bacteria, and the concentration of the cultured bacteria liquid reaches 10 10-11 /ml (ccu counting method), which is more than 5-10 times higher than that of ordinary culture medium.
实施例2和3中的猪肺炎支原体培养基进行与比较例1相同的应用,其最后也能达到与比较例1相同的技术效果。 The Mycoplasma hyopneumoniae culture medium in Examples 2 and 3 is applied in the same way as in Comparative Example 1, and it can finally achieve the same technical effect as that of Comparative Example 1.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310579845.6A CN103555641B (en) | 2013-11-19 | 2013-11-19 | A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310579845.6A CN103555641B (en) | 2013-11-19 | 2013-11-19 | A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103555641A CN103555641A (en) | 2014-02-05 |
CN103555641B true CN103555641B (en) | 2015-08-05 |
Family
ID=50010007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310579845.6A Active CN103555641B (en) | 2013-11-19 | 2013-11-19 | A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103555641B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104560835A (en) * | 2015-01-27 | 2015-04-29 | 新疆天康畜牧生物技术股份有限公司 | Culture medium for culturing mycoplasma hyopneumoniae and preparation method thereof |
CN105462840A (en) * | 2015-12-10 | 2016-04-06 | 浙江卫信生物药业有限公司 | Method for preparing living freeze-dried body of mycoplasma orale |
CN105779362A (en) * | 2016-05-16 | 2016-07-20 | 南京大爻网络科技有限公司 | Culture medium for low-serum culture of mycoplasma hyopneumoniae and preparation method and application thereof |
CN106591177B (en) * | 2016-11-29 | 2020-04-21 | 中国农业科学院兰州兽医研究所 | A low-serum high-efficiency culture medium of Mycoplasma capricolum subsp. capricolum and preparation method thereof |
CN106434502A (en) * | 2016-12-23 | 2017-02-22 | 瑞普(保定)生物药业有限公司 | Swine mycoplasma hyopneumoniae culture medium and preparation method and application thereof |
CN109010814B (en) * | 2018-08-31 | 2021-11-16 | 武汉科前生物股份有限公司 | Production method of haemophilus parasuis and mycoplasma hyopneumoniae bivalent inactivated vaccine |
CN109294955A (en) * | 2018-10-30 | 2019-02-01 | 南京大爻网络科技有限公司 | A kind of mycoplasma hyopneumoniae Pseudonocardia and preparation method thereof |
CN109468248A (en) * | 2018-12-14 | 2019-03-15 | 南京天邦生物科技有限公司 | A kind of porcine mycoplasmal pneumonia antigen high-efficient culture method |
CN110607260A (en) * | 2019-09-23 | 2019-12-24 | 山东甲骨文生物科技有限公司 | Culture medium and method for low-serum culture of mycoplasma hyopneumoniae |
CN110804563A (en) * | 2019-11-13 | 2020-02-18 | 山东滨州沃华生物工程有限公司 | Culture medium for low-serum culture of mycoplasma hyopneumoniae |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824119A (en) * | 2005-12-30 | 2006-08-30 | 广东工业大学 | A kind of preparation method and application of compound traditional Chinese medicine polysaccharide |
CN1928076A (en) * | 2006-09-28 | 2007-03-14 | 中国兽医药品监察所 | Live vaccine for mycoplasma pneumonia of swine and production method thereof |
CN102154167A (en) * | 2011-01-05 | 2011-08-17 | 北京大北农科技集团股份有限公司 | Mycoplasma hyopneumoniae culture medium and preparation method thereof |
CN103060220A (en) * | 2012-08-31 | 2013-04-24 | 南京天邦生物科技有限公司 | Low-serum culture medium for efficiently culturing mycoplasma hyopneumoniae and preparation method thereof |
-
2013
- 2013-11-19 CN CN201310579845.6A patent/CN103555641B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1824119A (en) * | 2005-12-30 | 2006-08-30 | 广东工业大学 | A kind of preparation method and application of compound traditional Chinese medicine polysaccharide |
CN1928076A (en) * | 2006-09-28 | 2007-03-14 | 中国兽医药品监察所 | Live vaccine for mycoplasma pneumonia of swine and production method thereof |
CN102154167A (en) * | 2011-01-05 | 2011-08-17 | 北京大北农科技集团股份有限公司 | Mycoplasma hyopneumoniae culture medium and preparation method thereof |
CN103060220A (en) * | 2012-08-31 | 2013-04-24 | 南京天邦生物科技有限公司 | Low-serum culture medium for efficiently culturing mycoplasma hyopneumoniae and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
"中药多糖对鼠李糖乳杆菌性质的影响";赵玉萍 等;《食品科技》;20050831(第8期);摘要 * |
"中药多糖的提取、分离纯化及其含量测定方法概述";郑晓艳 等;《福建分析测试》;20130831;第22卷(第4期);第58页右栏附图和第59页左栏第1.1.1节 * |
"中药多糖研究进展";王彦军;《医学理论与实践》;20090331;第22卷(第3期);第279页左栏第1段和第280页右栏第3段 * |
Also Published As
Publication number | Publication date |
---|---|
CN103555641A (en) | 2014-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103555641B (en) | A kind of mycoplasma hyopneumoniae culture medium and preparation method thereof | |
CN102154167B (en) | Mycoplasma hyopneumoniae culture medium and preparation method thereof | |
CN103409375B (en) | Virus diluent for inoculating chick embryo and preparation method of virus diluent | |
CN103495166B (en) | Preparation method of complex live vaccine for porcine reproductive and respiratory syndrome | |
CN110627919B (en) | A kind of intestinal prebiotic polysaccharide ORP-1 of Gallatella niger and its preparation method and use | |
CN111690554B (en) | Combined strain for preparing mycoplasma ovis pneumonia vaccine, mycoplasma ovis pneumonia trivalent inactivated vaccine and preparation method thereof | |
CN107050447A (en) | Porcine epidemic diarrhea virus inactivated vaccine and preparation method thereof | |
CN109913396B (en) | Liquid culture medium and method for separating and culturing mycoplasma gallisepticum by using same | |
CN116948901A (en) | Application of Weissella sinustrophus D-2 exopolysaccharide in inhibiting colon cancer cells | |
WO2008101428A1 (en) | Culture medium for lactobacillus acidophilus and streptococcus faecalis, composition comprising the same and preparation method thereof | |
CN106479936A (en) | Low blood serum medium of a kind of mycoplasma ovine pneumoniae and preparation method thereof | |
CN103550401B (en) | A kind of preparation method of composite microbial ecological agent effervescent tablet | |
CN100506996C (en) | A kind of fermentation preparation method of ganoderma lucidum polysaccharide | |
CN111514285A (en) | A triple inactivated vaccine of Mycoplasma sheep pneumoniae, Pasteurella multocida type A and Pasteurella multocida type D | |
WO2008098503A1 (en) | Culture medium for bifidobacterium longum, composition comprising the same and preparation method thereof | |
CN117562258B (en) | Application of animal bifidobacterium subspecies in promoting ginseng extract to play role in relieving liver injury | |
CN100368530C (en) | A kind of exopolysaccharide of bifidobacteria and its production method and special production strain | |
CN109010814B (en) | Production method of haemophilus parasuis and mycoplasma hyopneumoniae bivalent inactivated vaccine | |
CN103495162A (en) | Preparation method of porcine reproductive and respiratory syndrome compound inactivated vaccine | |
CN115181709B (en) | Mycoplasma hyopneumoniae culture medium | |
CN106282300A (en) | A kind of chicken virus mycoplasma detection method | |
CN108653454A (en) | Purposes of the Chinese medicine composition of the black pearl containing thorn in treating porcine contagious pleuropneumonia | |
CN103550770B (en) | Preparation method of compound effervescent tablets for treating chicken infectious bursal disease | |
CN107823536B (en) | Tibetan medicine composition for preventing and treating hemorrhagic septicemia caused by Pasteurella multocida and preparation method thereof | |
CN114129599A (en) | Application of silkworm chrysalis in the preparation of products for directional promotion of intestinal probiotics proliferation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A culture medium for Mycoplasma hyopneumoniae and its preparation method Granted publication date: 20150805 Pledgee: Agricultural Bank of China Limited by Share Ltd. Jinhua Economic Development Zone Branch Pledgor: ZHEJIANG MIBOLERONE BIOLOGICAL TECHNOLOGY Co.,Ltd. Registration number: Y2024980059143 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |